PWR
75
4
INTU
70
9
RSG
73
3
PPL
82
-2
VRSK
63
2
TRIP
47
3
LH
42
2
JNPR
65
2
MTB
52
-11
SLB
44
2
NVDA
59
7
VLO
40
2
CL
53
3
AMAT
52
2
XRAY
31
2
TSCO
43
4
LOW
55
2
SBUX
39
3
KR
65
-3
FMC
43
3
PWR
75
4
INTU
70
9
RSG
73
3
PPL
82
-2
VRSK
63
2
TRIP
47
3
LH
42
2
JNPR
65
2
MTB
52
-11
SLB
44
2
NVDA
59
7
VLO
40
2
CL
53
3
AMAT
52
2
XRAY
31
2
TSCO
43
4
LOW
55
2
SBUX
39
3
KR
65
-3
FMC
43
3
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Stock Predictions

Major Market Shift - Act Now Before it's Too Late

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
$45.00
Seasonality Move:
13.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Market's down 10% YTD Buffet's Berkshire up 13%

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

ProShares Ultra Nasdaq Biotechnology Stock Forecast

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 20.8% based on the past 15 years of stock performance.
  • ProShares Ultra Nasdaq Biotechnology has risen higher in 8 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.33%
  • Is ProShares Ultra Nasdaq Biotechnology Stock Undervalued?
    The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $44.61. The Score for BIB is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will ProShares Ultra Nasdaq Biotechnology Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 20.8% based on the past 15 years of stock performance.

ProShares Ultra Nasdaq Biotechnology Stock Rating

Sell
39
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology overpriced?

  • ProShares Ultra Nasdaq Biotechnology has risen higher in 8 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.33%

ProShares Ultra Nasdaq Biotechnology Stock Price History

Is BIB stock going to rise?

  • The current trend is relatively stagnant and BIB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
69.56
52-Week Low:
33.78

Prediction Charts

Market Cap:
0
Price in USD:
44.61
Volume:
2.8K
Beta:
1.83

Technical Analysis

SMA50:
49.60
SMA100:
51.99
SMA200:
57.81
52-Wk Change:
-8.85%

Stock Predictions

  • Is ProShares Ultra Nasdaq Biotechnology stock public?
    Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.
  • What is the ProShares Ultra Nasdaq Biotechnology stock quote today?
    The ProShares Ultra Nasdaq Biotechnology stock price is 44.61 USD today.
  • How to buy ProShares Ultra Nasdaq Biotechnology stock online?
    You can buy ProShares Ultra Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-7 37.60 39.41 41.60 36.22
Apr-8 40.81 36.99 40.82 36.43
Apr-9 35.47 40.66 41.07 33.78
Apr-10 38.07 37.54 38.69 35.33
Apr-11 37.72 40.24 40.30 37.72
Apr-14 40.92 42.55 42.85 40.77
Apr-15 42.46 42.21 42.82 41.66
Apr-16 41.68 40.72 41.68 40.00
Apr-17 40.81 41.39 41.45 40.58
Apr-21 41.62 40.79 42.00 40.60
Apr-22 41.27 43.05 43.05 41.27
Apr-23 44.92 44.35 45.70 44.30
Apr-24 44.01 46.00 46.00 44.01
Apr-25 44.69 44.61 45.40 44.43

ProShares Ultra Nasdaq Biotechnology Earnings

Data Unavailable

ProShares Ultra Nasdaq Biotechnology Forecast Revenue Growth

Data Unavailable

* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.